Status:
COMPLETED
HFNC and NIV for COVID-19 Complicated by Respiratory Failure
Lead Sponsor:
Chinese University of Hong Kong
Collaborating Sponsors:
Health and Medical Research Fund
Conditions:
Respiratory Failure
Eligibility:
All Genders
18+ years
Brief Summary
Background: Patients with COVID-19 have a range of clinical spectrum from asymptomatic infection, mild illness, moderate infection requiring supplemental oxygen and severe infection requiring intensiv...
Detailed Description
A novel coronavirus, subsequently named by the World Health Organization (WHO) as severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), emerged as the cause of atypical pneumonia linked to a s...
Eligibility Criteria
Inclusion
- Patients with confirmed COVID-19 who require treatment for respiratory failure
Exclusion
- inability to provide consent;
- severe respiratory failure requiring invasive ventilatory support;
- septic shock
Key Trial Info
Start Date :
June 11 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
April 30 2022
Estimated Enrollment :
26 Patients enrolled
Trial Details
Trial ID
NCT04452708
Start Date
June 11 2020
End Date
April 30 2022
Last Update
July 25 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Prince of Wales Hospital
Hong Kong, Hong Kong